Matinas Biopharma Hl MTNB

$1.18 +0.02 (1.72%)

Valuation

Market cap
1,166,000
Revenue TTM
$0
Net income TTM
$-10,350,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
16,086
Avg volume
90,713
Day's range
$1.15 – $1.22
Shares out
980,000
Stochastic %K
20%
Beta
2.24
Analysts
—
Price target
$50.00

Price

Company profile

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of...

Show more

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company was incorporated in 2013 and is based in Bedminster, New Jersey.

Industry
Biotechnology
Sector
Healthcare
Phone
908 484 8805
Website
https://www.matinasbiopharma.com
Address
1545 Route 206 South, Suite 302, Bedminster, United States

Latest news

Stocktwits

SmartMoneyTradez Nov 4, 9:10 PM
$EZGO Gap fill at 0.77 on watch $MTNB on watch
0 replies
JZen_ Nov 4, 8:11 PM
$MTNB Been watching this for a swing. Took a pretty nasty beating from the highs and is now sitting around $1.2. Not calling a bottom yet, but I like how it's trying to settle down here. The GH Power merger is what caught my attention. Originally expected to close in Q4, and we're already in November. They've also got a hydrogen offtake agreement in place, along with that potential TKMS collaboration. The chart's been beaten down pretty hard, but I'm watching to see if buyers step in around these lows. Still early, but with the merger catalyst pending, this could get interesting if volume starts picking up. The share count is tiny after the reverse split, so there's potential for a sharp move on the right volume. It still needs that $15M financing and merger approvals. JL
0 replies
Dailyfollower Nov 3, 6:26 PM
$MTNB 👎 $SRTM 👍
0 replies
JustTradeIt_ Nov 3, 2:26 PM
$MTNB quit SPOOFING the nbbo with that 1.24 Ask... you wanna sell, just put it up... 🤣
0 replies
Homer_Simpson82 Nov 3, 4:46 AM
$MTNB easy under 1
0 replies
Abo_Hamza Nov 2, 3:24 PM 0 replies
MomoMike Nov 2, 1:43 PM
$MTNB merger delayed?
0 replies
tdohm22 Oct 27, 7:55 PM 0 replies